by dissociating the tissue into small pieces and treating it with
collagenase (40 units/mL) for 2–4 h. Benign and cancer cells
of the kidney of a clear cell renal cell carcinoma patient cells were
grown as organoids in F-medium [3:1 (v/v) of F-12 nutrient mixture
(Ham)–DMEM (Invitrogen), 5% FBS, 8.4 ng/mL cholera toxin (Sigma),
0.4 μg/mL hydrocortisone (Sigma), 10 ng/mL epidermal growth
factor (Corning), 24 μg/mL adenine (Sigma), 5 μg/mL insulin
(Sigma), 10 μM ROCK inhibitor (Y-27632, Enzo Life Sciences,
Lausen, Switzerland), and 1% penicillin-streptomycin with 10% Matrigel
(Corning). The bladder tumor-derived organoids were grown in hepatocyte
calcium medium (Corning)49 (link) supplemented
with 5% CSFBS (Thermo Fisher Scientific), 10 μM Y-27632 RHO
inhibitor (Sigma), 10 ng/mL epidermal growth factor (Corning), 1%
GlutaMAX (Gibco), 1% penicillin-streptomycin, and 10% Matrigel. A
total of 6 × 106 cells were collected by centrifugation,
washed in PBS to remove Matrigel, and snap frozen before analyses.